X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK vs DR. REDDYS LAB - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK DR. REDDYS LAB MERCK/
DR. REDDYS LAB
 
P/E (TTM) x 51.6 21.9 235.1% View Chart
P/BV x 9.0 3.3 269.7% View Chart
Dividend Yield % 0.4 0.8 47.8%  

Financials

 MERCK   DR. REDDYS LAB
EQUITY SHARE DATA
    MERCK
Dec-17
DR. REDDYS LAB
Mar-18
MERCK/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,3582,788 48.7%   
Low Rs9331,902 49.1%   
Sales per share (Unadj.) Rs665.0860.8 77.3%  
Earnings per share (Unadj.) Rs56.657.1 99.1%  
Cash flow per share (Unadj.) Rs72.5122.0 59.4%  
Dividends per share (Unadj.) Rs15.0020.00 75.0%  
Dividend yield (eoy) %1.30.9 153.6%  
Book value per share (Unadj.) Rs441.7757.7 58.3%  
Shares outstanding (eoy) m16.60165.91 10.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.72.7 63.2%   
Avg P/E ratio x20.241.1 49.3%  
P/CF ratio (eoy) x15.819.2 82.2%  
Price / Book Value ratio x2.63.1 83.8%  
Dividend payout %26.535.0 75.7%   
Avg Mkt Cap Rs m19,011389,034 4.9%   
No. of employees `0001.523.5 6.6%   
Total wages/salary Rs m1,69632,149 5.3%   
Avg. sales/employee Rs Th7,150.06,070.8 117.8%   
Avg. wages/employee Rs Th1,098.71,366.6 80.4%   
Avg. net profit/employee Rs Th608.2402.5 151.1%   
INCOME DATA
Net Sales Rs m11,040142,810 7.7%  
Other income Rs m2401,552 15.4%   
Total revenues Rs m11,279144,362 7.8%   
Gross profit Rs m1,37623,512 5.9%  
Depreciation Rs m26410,772 2.5%   
Interest Rs m0788 0.0%   
Profit before tax Rs m1,35213,504 10.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0344 0.0%   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m5834,380 13.3%   
Profit after tax Rs m9399,468 9.9%  
Gross profit margin %12.516.5 75.7%  
Effective tax rate %43.132.4 132.9%   
Net profit margin %8.56.6 128.3%  
BALANCE SHEET DATA
Current assets Rs m7,523104,984 7.2%   
Current liabilities Rs m2,25368,938 3.3%   
Net working cap to sales %47.725.2 189.2%  
Current ratio x3.31.5 219.3%  
Inventory Days Days5274 70.1%  
Debtors Days Days41104 39.2%  
Net fixed assets Rs m1,240104,385 1.2%   
Share capital Rs m166830 20.0%   
"Free" reserves Rs m7,167124,886 5.7%   
Net worth Rs m7,333125,716 5.8%   
Long term debt Rs m025,089 0.0%   
Total assets Rs m9,912225,443 4.4%  
Interest coverage xNM18.1-  
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x1.10.6 175.8%   
Return on assets %9.54.5 208.3%  
Return on equity %12.87.5 170.1%  
Return on capital %20.89.7 213.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,01572,623 1.4%   
Fx outflow Rs m3,04318,916 16.1%   
Net fx Rs m-2,02853,707 -3.8%   
CASH FLOW
From Operations Rs m53718,030 3.0%  
From Investments Rs m-476-14,883 3.2%  
From Financial Activity Rs m-220-4,440 5.0%  
Net Cashflow Rs m-160-1,236 12.9%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 5.4 337.0%  
FIIs % 1.0 35.3 2.8%  
ADR/GDR % 0.0 18.5 -  
Free float % 29.1 15.3 190.2%  
Shareholders   28,591 75,885 37.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK With:   SUVEN LIFESCIENCES  SUN PHARMA  SANOFI INDIA  FDC LTD.  SHASUN PHARMA  

Compare MERCK With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Higher, IPO Buzz, and Top Cues in Focus Today(Pre-Open)

On Tuesday, Indian share markets witnessed most of the buying interest during closing hours and ended their trading session on a strong note.

Related Views on News

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

Why Super Investor Kenneth Andrade is Bullish on Agri Stocks...and So Are We(The 5 Minute Wrapup)

Jun 21, 2019

Andrade gives his take on agriculture, an industry from which we have already recommended two stocks.

This Little-Known Opportunity Promises Both Health and Wealth for Your Grandchildren(Profit Hunter)

Jun 20, 2019

The next big opportunity that has the potential to make you both rich and healthy.

My Upcoming Stock Recommendation, Backed by Aberdeen Standard Investments, Scores 9.1/10(The 5 Minute Wrapup)

Jun 19, 2019

This month's Smart Money Secrets recommendation is from global super investor - Aberdeen Standard Investments.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MERCK SHARE PRICE


Jun 25, 2019 (Close)

TRACK MERCK

COMPARE MERCK WITH

MARKET STATS